Revisions for CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial | Registro Público Cubano de Ensayos Clínicos

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial has 3 revisions.

Revision		Status
Saved 21/12/2020 - 11:23am by lazara		current revision (published)
Saved 21/12/2020 - 11:23am by lazara		archived
Saved 17/10/2018 - 4:43pm by Gladys		archived

Registered Trials

Registration process

About the RPCEC

Useful resources